BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

956 related articles for article (PubMed ID: 18042596)

  • 1. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
    Cardoso CR; Signorelli FV; Papi JA; Salles GF
    Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
    Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
    Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
    Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
    Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
    Cook RJ; Gladman DD; Pericak D; Urowitz MB
    J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
    Fragoso-Loyo HE; Sánchez-Guerrero J
    J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.
    Kwok SK; Ju JH; Cho CS; Kim HY; Park SH
    Lupus; 2009 Jan; 18(1):16-21. PubMed ID: 19074164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A; Nossent HC
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
    Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
    Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
    Laustrup H; Voss A; Green A; Junker P
    Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
    Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
    Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
    Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
    Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
    Ibañez D; Gladman D; Urowitz M
    J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.